Style | Citing Format |
---|---|
MLA | Khezerloo D, et al.. "Dosimetric Properties of New Formulation of Presage® With Tin Organometal Catalyst: Development of Sensitivity and Stability to Megavoltage Energy." Journal of Cancer Research and Therapeutics, vol. 14, no. 2, 2018, pp. 308-313. |
APA | Khezerloo D, Nedaie HA, Takavar A, Zirak A, Farhood B, Banaee N, Alidokht E (2018). Dosimetric Properties of New Formulation of Presage® With Tin Organometal Catalyst: Development of Sensitivity and Stability to Megavoltage Energy. Journal of Cancer Research and Therapeutics, 14(2), 308-313. |
Chicago | Khezerloo D, Nedaie HA, Takavar A, Zirak A, Farhood B, Banaee N, Alidokht E. "Dosimetric Properties of New Formulation of Presage® With Tin Organometal Catalyst: Development of Sensitivity and Stability to Megavoltage Energy." Journal of Cancer Research and Therapeutics 14, no. 2 (2018): 308-313. |
Harvard | Khezerloo D et al. (2018) 'Dosimetric Properties of New Formulation of Presage® With Tin Organometal Catalyst: Development of Sensitivity and Stability to Megavoltage Energy', Journal of Cancer Research and Therapeutics, 14(2), pp. 308-313. |
Vancouver | Khezerloo D, Nedaie HA, Takavar A, Zirak A, Farhood B, Banaee N, et al.. Dosimetric Properties of New Formulation of Presage® With Tin Organometal Catalyst: Development of Sensitivity and Stability to Megavoltage Energy. Journal of Cancer Research and Therapeutics. 2018;14(2):308-313. |
BibTex | @article{ author = {Khezerloo D and Nedaie HA and Takavar A and Zirak A and Farhood B and Banaee N and Alidokht E}, title = {Dosimetric Properties of New Formulation of Presage® With Tin Organometal Catalyst: Development of Sensitivity and Stability to Megavoltage Energy}, journal = {Journal of Cancer Research and Therapeutics}, volume = {14}, number = {2}, pages = {308-313}, year = {2018} } |
RIS | TY - JOUR AU - Khezerloo D AU - Nedaie HA AU - Takavar A AU - Zirak A AU - Farhood B AU - Banaee N AU - Alidokht E TI - Dosimetric Properties of New Formulation of Presage® With Tin Organometal Catalyst: Development of Sensitivity and Stability to Megavoltage Energy JO - Journal of Cancer Research and Therapeutics VL - 14 IS - 2 SP - 308 EP - 313 PY - 2018 ER - |